Old drug thalidomide tested for new use: healing radiation-damaged intestines
NCT ID NCT06617182
Summary
This study is testing whether thalidomide combined with glutamine can help control bleeding and other symptoms in people who developed intestinal damage after radiation therapy for cancer. Researchers will enroll 150 adults who experience frequent bloody bowel movements due to this condition. Participants will receive one of three treatment plans for 8 weeks while researchers track their bleeding, hospital visits, and overall improvement.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIATION ENTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Department of Gastroenterology & Hepatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Ch
RECRUITINGXi'an, Shaanxi, 710005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.